Cargando…
Discontinuation of alpha-blocker therapy in men with lower urinary tract symptoms: a systematic review and meta-analysis
OBJECTIVES: We aimed to synthesise the available data for the effect of stopping alpha-blocker therapy among men with lower urinary tract symptoms. The focus was on symptom, uroflowmetry and quality of life outcomes, but we also reviewed the adverse events (AEs) and the number of patients who restar...
Autores principales: | van der Worp, Henk, Jellema, Petra, Hordijk, Ilse, Lisman-van Leeuwen, Yvonne, Korteschiel, Lisa, Steffens, Martijn G, Blanker, Marco H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6858108/ https://www.ncbi.nlm.nih.gov/pubmed/31699724 http://dx.doi.org/10.1136/bmjopen-2019-030405 |
Ejemplares similares
-
Patients’ Attitudes Towards Deprescribing Alpha-Blockers and Their Willingness to Participate in a Discontinuation Trial
por: Edelman, Malou, et al.
Publicado: (2019) -
Continuation rates of alpha-blockers mono-therapy in adult men, prescribed by urologists or general practitioners: a pharmacy-based study
por: Hordijk, Ilse M. J., et al.
Publicado: (2018) -
Effectiveness and costs of a new framework for selecting absorbent urinary incontinence products compared with current practice: a cohort study
por: Schreuder, Miranda C, et al.
Publicado: (2022) -
Symptom improvement and predictors associated with improvement after 6 weeks of alpha-blocker therapy: An exploratory, single-arm, open-label cohort study
por: van der Worp, Henk, et al.
Publicado: (2019) -
Effectiveness of a newly developed online self‐management program for male patients with uncomplicated lower urinary tract symptoms
por: Blanker, Marco H., et al.
Publicado: (2019)